Skip to content

A Prospective, Observational Trial on the Diagnostic and Prognostic of LM

A Prospective, Observational Trial on the Diagnostic and Prognostic Value of Cell-free DNA in Advanced Lung Cancer With Leptomeningeal Metastases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02607605
Acronym
ctDNA
Enrollment
10
Registered
2015-11-18
Start date
2015-08-31
Completion date
2020-08-31
Last updated
2017-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms, Meningeal Carcinomatosis

Keywords

lung cancer, leptomeningeal metastases, cell-free DNA

Brief summary

The primary purpose of this study is to compare the positive rate between the cell-free DNA and cytological examination of cerebrospinal fluid in Advanced lung cancer with leptomeningeal metastases.

Interventions

None listed

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Patient who was confirmed primary lung cancer by pathologic histology or cytology 2. Adult patients (≥18 years and ≤75 years). ECOG Performance Status 0 or 1.Life expectancy of at least 12 weeks. 3. Clinical symptoms and imaging tests are highly suspicious of advanced lung cancer with leptomeningeal metastases 4. Without contraindications to lumbar puncture

Exclusion criteria

1. Patients who have primary benign or malignant brain tumor and metastatic malignant brain tumor 2. Patients who have contraindications to lumbar puncture 3. Serious uncontrolled systemic disease including active infection,uncontrolled hypertension,diabetes,unstable angina,congestive heart failure,myocardial infarction,severe arrhythmia which needs drugs,hepatic、renal and metabolic disease

Design outcomes

Primary

MeasureTime frame
positive rate between the cell-free DNA and cytological examination of cerebrospinal fluid2 years

Secondary

MeasureTime frame
The relationship between the number of cell-free DNA and OS2 years

Countries

China

Contacts

Primary Contactli-kun chen, Doctor
chenlk@sysucc.org.cn13798019964

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026